Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06597513
What this trial is testing

Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Zhou Chengzhi 10
Large-scale testing (Phase 3)Study completedNCT00949650
What this trial is testing

BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation

Who this might be right for
Carcinoma, Non-Small-Cell LungAdenocarcinoma
Boehringer Ingelheim 345
Large-scale testing (Phase 3)Study completedNCT03691090
What this trial is testing

Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer

Who this might be right for
Advanced Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 596
Testing effectiveness (Phase 2)Study completedNCT01206036
What this trial is testing

CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)

Who this might be right for
Prostatic Neoplasms
Central European Society for Anticancer Drug Research 19
Large-scale testing (Phase 3)Not Yet RecruitingNCT07796100
What this trial is testing

ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd. 530
Testing effectiveness (Phase 2)Study completedNCT00524810
What this trial is testing

Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
ARCAGY/ GINECO GROUP 67
Testing effectiveness (Phase 2)UnknownNCT06331650
What this trial is testing

A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease 30
Testing effectiveness (Phase 2)Looking for participantsNCT06536868
What this trial is testing

Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Second Hospital of Shanxi Medical University 40
Testing effectiveness (Phase 2)Study completedNCT00112697
What this trial is testing

Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
UNICANCER 71
Large-scale testing (Phase 3)Looking for participantsNCT04638790
What this trial is testing

First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)

Who this might be right for
Hodgkin Lymphoma, Adult
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 300
Testing effectiveness (Phase 2)Study completedNCT02107937
What this trial is testing

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian NeoplasmsOvarian Epithelial Cancer
SOTIO a.s. 136
Testing effectiveness (Phase 2)Study completedNCT02263495
What this trial is testing

Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Asan Medical Center 118
Testing effectiveness (Phase 2)Looking for participantsNCT06776757
What this trial is testing

Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07595172
What this trial is testing

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Locally Advanced and Metastatic Pancreatic Cancer
West China Hospital 55
Large-scale testing (Phase 3)UnknownNCT02886195
What this trial is testing

EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC

Who this might be right for
EGFR Gene Mutation
Fujian Cancer Hospital 120
Not applicableStudy completedNCT01506167
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 719
Large-scale testing (Phase 3)Study completedNCT03088540
What this trial is testing

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma，Non-Small-Cell LungLung Carcinomas, Non-Small-CellNon-small-cell Lung Carcinoma+1 more
Regeneron Pharmaceuticals 712
Testing effectiveness (Phase 2)Study completedNCT04647344
What this trial is testing

AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer Non-Small Cell Stage IIIB/IIIC/IV
Akeso 46
Testing effectiveness (Phase 2)Ended earlyNCT00872404
What this trial is testing

CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma

Who this might be right for
Head and Neck Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 37
Large-scale testing (Phase 3)UnknownNCT00949455
What this trial is testing

A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium

Who this might be right for
Bladder Cancer
Queen Mary University of London 204
Next Page